About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Circulation: Heart Failure
›
Top Articles
Circulation: Heart Failure
7.6
(top 1%)
Impact Factor
8.5
(top 1%)
extended IF
122
(top 3%)
H-Index
2.2K
authors
1.8K
papers
68.9K
citations
3.8K
citing journals
32.6K
citing authors
Most Cited Articles of Circulation: Heart Failure
Title
Year
Citations
Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association
2013
1.6K
Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction
2010
650
Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction
2011
371
Recent national trends in readmission rates after heart failure hospitalization
2010
326
Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis
2013
309
Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy
2010
306
PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study
2011
298
Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure
2008
292
Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function
2012
288
Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy
2012
285
Exercise training in patients with heart failure and preserved ejection fraction: meta-analysis of randomized control trials
2015
270
High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure
2011
268
Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model
2009
260
The development of aortic insufficiency in left ventricular assist device-supported patients
2010
259
Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction
2014
256
Exercise training in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial
2010
256
Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling
2009
256
Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy: results of the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region trial
2013
253
Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction
2015
249
Large animal models of heart failure: a critical link in the translation of basic science to clinical practice
2009
239
Prevalence of left ventricular diastolic dysfunction in a general population
2009
233
Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction
2010
227
Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device
2010
226
Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy
2008
224
Comparative safety and effectiveness of metformin in patients with diabetes mellitus and heart failure: systematic review of observational studies involving 34,000 patients
2013
222
previous
2011
2012
2013
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.